Finance

Lists
600613:SHA
Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CNÂ¥9.02
-0.77%
(-0.070) 1D
Sep 4, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600613...
Open
CNÂ¥9.12
High
CNÂ¥9.39
Low
CNÂ¥8.76
Mkt. cap
4.49B
Avg. vol.
59.47M
Volume
114.41M
Dividend
0.78%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
133.35
52-wk high
CNÂ¥12.77
52-wk low
CNÂ¥4.33
EPS
CNÂ¥0.07
Shares outstanding
479.32M
No. of employees
1K
Open
CNÂ¥9.12
High
CNÂ¥9.39
Low
CNÂ¥8.76
Mkt. cap
4.49B
Avg. vol.
59.47M
Volume
114.41M
Dividend
0.78%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
133.35
52-wk high
CNÂ¥12.77
52-wk low
CNÂ¥4.33
EPS
CNÂ¥0.07
Shares outstanding
479.32M
No. of employees
1K
About Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CEO-
Employees1.2K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitegzsq.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
437.01M
554.51M
422.94M
425.19M
Cost of goods sold
221.29M
348.47M
232.06M
242.92M
Cost of revenue
221.29M
348.47M
232.06M
242.92M
Research and development expenses
7.91M
8.48M
7.04M
7.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169.03M
186.17M
148.02M
136.29M
Operating expense
185.83M
211.87M
169.08M
141.93M
Total operating expenses
407.11M
560.34M
401.14M
384.85M
Operating income
29.90M
-5.83M
21.80M
40.34M
Other non operating income
-1.06M
-1.07M
-1.84M
-7.57M
EBT including unusual items
19.70M
5.71M
19.41M
17.69M
EBT excluding unusual items
29.63M
-5.90M
19.66M
33.59M
Income tax expense
3.03M
16.97M
7.38M
4.21M
Effective tax rate
15.36%
296.96%
38.03%
23.82%
Other operating expenses
8.98M
3.52M
9.92M
2.05M
Net income
17.49M
-12.06M
12.88M
9.08M
Net profit margin
4.00%
-2.17%
3.05%
2.14%
Earnings per share
-
-
-
-
Interest and investment income
1.85M
4.08M
2.07M
2.37M
Interest expense
-1.07M
-3.10M
-2.37M
-1.55M
Net interest expenses
783.54K
983.79K
-305.41K
820.74K
Depreciation and amortization charges
-
-
-
-
EBITDA
49.34M
12.75M
40.38M
60.70M
Gain or loss from assets sale
-
-227.96K
-
-51.12K
AI content may include mistakes. Learn more
Google apps